Johnson & Johnson's drug problem
5:35pm: Bill Weldon, Johnson & Johnson's longtime CEO, will step down after a slew of recalls. More
Apr 14: Johnson & Johnson recalls 57,000 bottles of the prescription anti-seizure medication after consumers complain of 'uncharacteristic odor.' More
Mar 29: Johnson & Johnson's McNeil unit recalls 34,000 bottles of Tylenol 8 hour caplets following complaints of musty, moldy odor. More
Mar 11: Analysts see pros and cons to government oversight of the Johnson & Johnson's factories that make Tylenol, Motrin and Benadryl. More
Mar 10: The government has taken over three plants operated by Johnson & Johnson's troubled McNeil divison, maker of Tylenol, Motrin and Benadryl drugs. More
Dec 2: Recall of 12 million bottles of stomach discomfort treatment, along with AlternaGel, made with Merck is latest in a series of Johnson & Johnson recalls. More
Oct 19: Drug safety agency says latest recalled adult Tylenol was manufactured at the Fort Washington plant that made recalled children's Tylenol. More
Oct 19: Successive over-the-counter drugs recalls erode Johnson & Johnson's sales; announces fresh Tylenol recall. More
Sep 30: Congress may be grilling Johnson & Johnson over its phantom recall. But Wall Street could care less about the company's bad PR. More
Sep 30: In his first appearance before lawmakers, William Weldon said he takes responsibility for J&J's recall woes. He also admits company clearly hid a Motrin recall effort from regulators. More
Sep 30: Lawmakers say Johnson & Johnson conducted a 'phantom' Motrin recall, what is that? More
Sep 29: A day before Congressional hearings into the company's drug recall woes, William Weldon says some of the recalled children's drugs will return to stores next week. More
Sep 28: Regulators tell Johnson & Johnson, CVS and Walgreens to stop product claims that their mouth rinses remove plaque or prevent gum disease. More
Sep 22: Congressional committee investigating Johnson & Johnson's phantom Motrin recall said company failed to produce proof that regulators approved its activities. More
Sep 21: An email exchange between an FDA official and a Johnson & Johnson executive indicates that regulators called out drugmaker for trying to pass off recall as a 'retrieval.' More
Sep 20: As lawmakers and regulators investigate the goings on at the company, a disturbing picture is emerging. More
Sep 16: New documents reveal that Johnson & Johnson may have been organizing a secret recall of children's Tylenol months before officially recalling the drugs. More
Aug 26: DePuy Orthopaedics says more people than expected have experienced pain and second surgery following receiving its ASR hip replacement and resurfacing systems. More
Aug 24: Agency warns Johnson & Johnson unit that it has been selling TruMatch products and the Corail Hip System without its approval. More
Aug 24: Surge in high-profile drug and food recalls may prompt the government to bring criminal action against executives. More
Aug 16: Industry report says drug recalls in the U.S. hit a new record in 2009, raising questions about an overall decline in the quality of drug manufacturing. More
Aug 6: Recalls of Tylenol, Motrin and Benadryl have not only made these top brands vulnerable -- they've created an opening for generic drugs. More
Jul 23: After its Tylenol recalls, a Johnson & Johnson Pepcid plant shows similar serious lapses as in the shuttered Tylenol plant in Fort Washington. More
Jul 20: Company says it has received a grand jury subpoena in connection with multiple recalls of its non-prescription drugs. More
Jul 16: Drug safety agency fails to issue a clean bill of health on another factory that makes over-the-counter drugs. More
Jul 15: The manufacturing facility at the center of a recall of millions of over-the-counter children's drugs is eliminating most of its workforce. More
Jun 24: The drug-making arm of Johnson & Johnson said it expects delays in replenishing the supply of medicines made at a plant it shut in May. More
Jun 23: Government inspections of McNeil's Fort Washington facility reveal a timeline of quality and safety lapses. More
Jun 16: Five months after McNeil recalled millions of Tylenol and Motrin bottles for foul odor, stores shelves are still empty. More
Jun 7: Congressional committee investigating McNeil's 'phantom' Motrin recall say they haven't received needed documents, sources say a subpoena could be next. More
Jun 2: FDA says memo to contractor shows drugmaker McNeil initiated an 'unusual' clandestine recall of Motrin in 2009. More
May 25: Embattled drugmaker pledges to overhaul it's production methods and quality. More
May 25: Reports of illness and death are being investigated by the FDA ahead of a Congressional hearing on drugs recalled by Johnson & Johnson. More
May 14: Experts say reported quality, safety violations at the Johnson & Johnson plant so egregious that the FDA might consider permanently shutting facility. More
May 5: U.S. says Burkholderia cepacia was in drums found at the children's medicine factory; says bacteria hasn't been found in finished products. More
May 4: U.S. says Johnson & Johnson dragged its feet to respond to consumer complaints; failed to meet minimum quality standards. Drug maker suspends production at the plant. More
May 3: McNeil said Monday that it will implement 'corrective actions' at its U.S. plant after some 40 children's drugs including Tylenol and Motrin were recalled over quality concerns. More
Jan 26: Don't blame us for your tainted products, wooden pallet industry tells Johnson & Johnson in a warning letter. More
Jan 15: New complaints of 'moldy' odor triggers fresh recall of several over-the-counter drugs. 'The company should have acted faster,' FDA says. More

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer. Morningstar: © 2018 Morningstar, Inc. All Rights Reserved. Factset: FactSet Research Systems Inc. 2018. All rights reserved. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2018 and/or its affiliates.